No Detail Found!

Comparison of Presentation and Outcome in 100 Pediatric Hodgkin Lymphoma Patients Treated at Children Hospital, Lahore, Pakistan and Royal Marsden Hospital, UK.

Author(s)
Mahwish Faizan Department of Paediatric Haematology/Oncology and Bone Marrow Transplant, Birmingham Children Hospital, Steel House Lane, B4 6NH Birmingham, UK
Mary M. Taj Department of Paediatric Oncology, Royal Marsden Hospital, Downs Road, Sutton, London, UK SM2 5PT
Saadia Anwar Department of Haematology/Oncology, The Children Hospital and ICH, Ferozepur Road, Lahore, Pakistan
Nyla Asghar Department of Haematology/Oncology, The Children Hospital and ICH, Ferozepur Road, Lahore, Pakistan
Alia Ahmad Department of Haematology/Oncology, The Children Hospital and ICH, Ferozepur Road, Lahore, Pakistan
Donna Lancaster Department of Paediatric Oncology, Royal Marsden Hospital, Downs Road, Sutton, London, UK SM2 5PT
Ayad Atra Department of Paediatric Oncology, Royal Marsden Hospital, Downs Road, Sutton, London, UK SM2 5PT
Agha Shabbir Ali Department of Paediatrics, Lahore General Hospital and PGMI, Lahore, Pakistan
Abstract
Objective: To compare differences in demographics and outcomes in childhood Hodgkin lymphoma (HL) presenting at the Children's Hospital Lahore (CHL), and Royal Marsden Hospital (RMH), UK. Study Design: An observational comparative study. Place and Duration of Study: From January 2011 to February 2012 at CH, Lahore and from October 2008 to February 2012 at RMH, UK. Methodology: Consecutive HL patients (50 from each hospital) were inducted. Data regarding age, gender, staging, histopathology and outcome were analysed. Clinical and pathological staging done according to Ann-Arbor and World Health Organization classification. Treatment duration was 6-8 months. They were followed for 6 months post-treatment. Frequencies of variables were noted and compared. Chi-square test was used for determining significance. Results: Patients from Children's Hospital, Lahore were younger (mean 7.9 years) with male predominance (n=42, 84%). Histopathology showed Mixed Cellularity (MC) in 32 (64%), Nodular Sclerosis (NS) in 5 (10%), Lymphocyte Rich in 4 (8%) and lymphocyte depleted in 1 (2%), nodular lymphocyte predominant (NLP) in 1 (2%) each. Majority presented in stage IV (n=25,50%), or stage III (n=20,40%). Constitutional B symptoms were present in 37 (74%). Bone marrow involvement observed in 23 (46%). Remission was achieved in 42 (84%) patients; 2 (4%) relapsed, 4 (8%) expired and 2 (4%) left against medical advice. In contrast, RMH patients were older (mean 11.8 years.) and 30 (60%) were males. NS (n=40,80%) and NLP (n=6,12%) types were predominant. Two (4%) patients were in stage I, 27 (54%) in stage II, 12 (24%) in stage III and 9 (18%) presented in stage IV. Fourteen (28%) had B-symptoms. None had bone marrow disease. Event free survival was 46 (92%). Four (8%) patients relapsed. Three responded to second line therapy and one relapsed postautologous transplant. Conclusion: Significant differences were observed in age at presentation, stage, histopathology and extent of bone marrow involvement between the groups. Of interest is the bone marrow involvement in stage IV patients in Pakistan. Delayed diagnosis account for advanced stage but difference in pathological subtype needs further study.
Publication Details
Page(s) 904-907
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 26, Issue: 11, Year: 2016

Request the full text from PASTIC

References
2014.epidemiology and end results (SEER) program (www,cancer.gov) -
Mauz-KorholzC,HasencleveD,DorffelW., 2010.Procarbazine-free OEPA-COPDAC chemotherapy in boys and standard OPPACOPP in girls have comparable effectiveness in pediatric Hodgkin's lymphoma: The GPOH-HD-2002 study,J Clin Oncol 28 3680 -6
SchellongG,PotterR,BramswigJ, 1999.High cure rates and reduced long-term toxicity in pediatric Hodgkin's disease: The German-Austrian multicenter trial DAL-HD-90. The GermanAustrian Pediatric Hodgkin's Disease Study Group,J Clin Oncol 17 3736 -44
AhmedN,BhurgriY,SadiqS,ShakoorKA, 2007.Pediatric brain tumours at a tertiary care hospital in Karachi,Asian Pac J Cancer Prev 8 399 -404
KusumakumaryP,JacobR,JothirmayiR,NairMK, 2000.Profile of pediatric malignancies: A ten year study,Indian Pediatr 37 1234 -8
GruffermanS,DelzellE., 1984.Epidemiology of Hodgkin's disease,Epidemiol Rev 6 76 -106
2011.Cancer statistic registrations: Registrations of cancer diagnosed in 2008, -
DinandV,AryaLS, 2006.Epidemiology of childhood Hodgkins disease: Is it different in developing countries?,Indian Pediatr 43 141 -7
SiddiquiN,AyubB,BadarF,ZaidiA, .Hodgkin's lymphoma in Pakistan: A clinicoepidemiological study of 658 cases at a, -
ClaviezA,TiemannM,Luders H, 2005.Impact of latent Epstein-Barr virus infection on outcome in children and adolescents with Hodgkin's lymphoma,J Clin Oncol 23 4048 -56
AraujoI,BittencourtAL,BarbosaHS, 2006.The high frequency of EBV infection in pediatric Hodgkin lymphoma is related to the classical type in Bahia, Brazil,Virchows Arch 449 315 -9
JarrettRF,StarkGL,WhiteJ, 2005.Impact of tumor Epstein-Barr virus status on presenting features and outcome in agedefined subgroups of patients with classic Hodgkin lymphoma: A population-based study,Blood 106 2444 -51
MakarRR,SajiT,JunaidTA, 2003.Epstein-Barr virus expression in Hodgkin's lymphoma in Kuwait,Pathol Oncol Res 9 159 -65
NadeemM,NaqiN,HussainI., 2009.Frequency of bone marrow involvement in Hodgkin's lymphoma on first presentation,J Coll Physicians Surg Pak 19 768 -71
ChandraJ,NaithaniR,SinghV, 2008.Developing anticancer chemotherapy services in a developing country: Hodgkin lymphoma experience,Pediatr Blood Cancer 51 485 -8
FadooZ,BelgaumiA,AlamM., .Pediatric lymphoma: A 10-year experience at a tertiary care hospital in Pakistan,J Pediatr Hematol Oncol 2010 32 14 -8
ColbyTV,HoppeRT,WarnkeRA, 1982.Hodgkin's disease: A clinicopathologic study of 659 cases,Cancer 49 1848 -58
GualcoG,KlumbCE,BarberGN, 2010.Pediatric lymphomas in Brazil,Clinics (Sao Paulo) 65 1267 -77
BuyukpamukcuM,VaranA,AkyuzC., 2009.The treatment of childhood Hodgkin lymphoma: Improved survival in a developing country,Acta Oncol 48 44 -51
ChirdanLB,Bode-ThomasF,ChirdanOO, 2009.Childhood cancers: Challenges and strategies for management in developing countries,Afr J Paediatr Surg 6 126 -30
0

Citations

0

Downloads

56

Views